Post-Conference Report
This report provides a comprehensive guide to cell therapy abstracts presented at the conference. It includes an analysis of these abstracts, focusing on the distribution of therapeutic class, disease indication and target. Additionally, it provides a summary breakdown that includes:
- Trial Sponsors: Overview of key sponsors behind the trials.
- Clinical Phases: Summary of the clinical phases represented, from early-stage to advanced research.
- Disease Indications and Results: Comprehensive look at disease indications covered and trial outcomes.
- Safety Outcomes: Analysis of safety data for these therapies.
We hope you find this report valuable and insightful and are as excited as we are to see the latest developments in cell therapy.
Pre-Conference Planner
Organized according to their presentation sequence at the 2024 meeting, the pre-conference planner details 29 clinical and 85 preclinical cell therapy abstracts.
Each abstract includes vital details such as the abstract ID, title, trial ID, sponsor, presentation time, and location. Additionally, every abstract includes unique links for direct access to the corresponding drug or trial page within Beacon Cell Therapy.
Beacon Cell Therapy
How the most complete cell therapy database can help you
What we cover
Beacon Cell Therapy sector-specific curated database includes trial and drug records for preclinical, active, approved, and discontinued:
- Receptor-engineered cell therapies such as CAR (chimeric antigen receptor) and TCR (T-cell receptor) therapies
- Other engineered or non-engineered immune cell therapies such as natural killer cells and regulatory T cells (Tregs)
- Stem cell-derived and iPSC-derived cell therapies such as immune cells, somatic cells (e.g. cardiomyocytes and retinal pigment cells) and precursor cells
How Beacon Cell Therapy works
Search the clinical trial and drug landscape with over 15 filters, including cell type, cell source, and starting material, enabling you to extract the data you need to conduct complex analyses efficiently.
Our unique Milestones filter and visualization highlights past, present, and future drug development milestones, including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the cell therapy space.
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
At Beacon, we are committed to empowering our pharmaceutical and biotech industry partners with accurate, comprehensive data. We are not just a tool; we see ourselves as a partner in the drug development journey. Contact us to learn how we help you.
